We found that 92.5% iCCAs can be classified as iCCAphl and iCCApps according to the expression of S100P and SPP1, and there are significant differences in clinicopathological characteristics, gene regulatory networks, and immune infiltration between these two iCCA subtypes. This evidence concerns the gene S100P and infantile convulsions and choreoathetosis.